Limited Competition: Institutional Development Award (IDeA) for Clinical & Translational Research (CTR) (P30 - CT Optional)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 19 Aug 2026
- Closes
- 30 May 2029, 23:59 UTC
- Reference
- PAR-27-056
- Location
- United States
- Sector
- Healthcare & Pharma
At a glance
National Institutes of Health in United States has published a funding call in healthcare & pharma: “Limited Competition: Institutional Development Award (IDeA) for Clinical & Translational Research (CTR) (P30 - CT Optional)”. Submissions close on 30 May 2029, 929 days from today. Quote reference PAR-27-056 in any correspondence with the buyer. FreeTender has recorded 459 notices from this buyer since 2023, 368 of them currently open. There are 389 open healthcare & pharma notices in United States on FreeTender. Bids are submitted to the buyer through Grants.gov — US federal funding opportunities, not through FreeTender.
Key requirements
Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.
To bid on Grants.gov (US federal)
Applicants need a UEI from SAM.gov and a Grants.gov account registered to their organisation; allow several weeks for registration.
Details
The Institutional Development Award (IDeA) program develops biomedical research capacity in states that have historically received low levels of NIH funding (IDeA states). The IDeA Clinical & Translational Research (CTR) program supports two programmatic tracks to build clinical and translational (C&T) research capacity to enable research on diseases and health challenges prevalent in IDeA states. IDeA CTR Development (CTR-D) awards focus on C&T research workforce development and infrastructure enhancement at health research organizations with limited clinical research capacity in IDeA states. IDeA CTR Network (CTR-N) awards support statewide (or multi-state) networks of health research organizations to expand existing infrastructure, develop the research workforce to enhance the network organization's ability to design and implement competitive C&T research programs, and coordinate clinical research activities state-wide and/or across IDeA states.This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered. Eligibility: Eligibility Criteria for Lead and Partner OrganizationsEvery organization in the application must be either a Lead or a Partner–no organization can be both.Every organization in the application must be in an IDeA-eligible state.There are strict limits to avoid overlap:Each IDeA-eligible state can only have one active IDeA-CTR-type (IDeA-CTR, CTR-N, or CTR-D) award at a time.An organization can only be involved in one IDeA-CTR-type award at a time.Organizations may not serve as a lead, partner or otherwise participate with an active Clinical and Translational Science Award (CTSA). Organizations must meet all eligibility rules at the time of application submission and award.Additional Eligibility Criteria for Lead OrganizationsTo apply as the lead, the organization must:Already have externally-funded clinical and translational (C&T) research.Additional Eligibility Criteria for Partner OrganizationsTo participate as a partner, the organization mustBe in the same state or multi-state region as the lead organization.Note:Active awards include awards in no-cost extension (NCE).An organization that currently leads an active IDeA-CTR-type award may submit a new application if substantial changes to the CTR are proposed. If the new application is funded, the current award will be administratively ended before the new award begins.
CFDA number(s): 93.859
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Context for bidders
We hold 459 notices from National Institutes of Health, going back to May 2023 — 368 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 389 open Healthcare & Pharma tenders in United States. This one closes in 929 days.
More from this buyer
- Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (UM1 Clinical Trial Required)· closes 10 Jun
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed)· closes 5 Mar
- Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care (RP1- Clinical Trial Optional)· closes 17 Feb
- NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)· closes 20 Feb
- Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)· closes 10 Oct
Similar Healthcare & Pharma tenders
- Research Grants Supporting Scientific Discovery, Academic Research and New Studies· closes 18 Jan
- Tele-Emergency (Tele-Ed) High-Acuity Emergency Support and Telemedicine Sexual Assault Medical Forensic Evaluation support services for Great Plains Area Indian Health Service Units· closes 8 Dec
- Litter, Folding, Pole — 67 each, NSN 6530016631222· closes 18 Nov
- Jacobs Creek JCC Medical Services — General Health Care Services· closes 17 Nov
- Blanket, Survival — 3000 each, NSN 6532015246932· closes 19 Nov
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- Поставка приспособлений зуботехнических на 2027 годБЮДЖЕТНОЕ УЧРЕЖДЕНИЕ ХАНТЫ-МАНСИЙСКОГО АВТОНОМНОГО ОКРУГА - ЮГРЫ "ЛАНГЕПАССКАЯ ГОРОДСКАЯ БОЛЬНИЦА" · Russia
- Поставка лекарственного препарата для медицинского применения хлоргексидинМИНИСТЕРСТВО ПО РЕГУЛИРОВАНИЮ КОНТРАКТНОЙ СИСТЕМЫ В СФЕРЕ ЗАКУПОК ВОРОНЕЖСКОЙ ОБЛАСТИ · Russia
- Поставка изделий медицинского назначения для отделения реанимацииГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ РЕСПУБЛИКИ КОМИ "ИНТИНСКАЯ ЦЕНТРАЛЬНАЯ РАЙОННАЯ БОЛЬНИЦА" · Russia
- Поставка лекарственного препарата для медицинского применения цефотаксимМИНИСТЕРСТВО ПО РЕГУЛИРОВАНИЮ КОНТРАКТНОЙ СИСТЕМЫ В СФЕРЕ ЗАКУПОК ВОРОНЕЖСКОЙ ОБЛАСТИ · Russia
- Субсидия на приобретение основных средств стоимостью до 400 тыс. рублей за единицу:монитор пациента многопараметрический для взрослых, монитор пациента многопараметрический для новорожденныхГОСУДАРСТВЕННОЕ АВТОНОМНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ СВЕРДЛОВСКОЙ ОБЛАСТИ "ДЕТСКАЯ ГОРОДСКАЯ БОЛЬНИЦА ГОРОД КАМЕНСК-УРАЛЬСКИЙ" · Russia
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →